HUT vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
HUT exhibits severe fundamental distress, highlighted by a critical Piotroski F-Score of 1/9, indicating a near-total failure of financial health metrics. While the stock has seen massive 1-year price appreciation and maintains a 'strong_buy' analyst consensus, there is a dangerous disconnect between market sentiment and operational reality. The company suffers from an unsustainable operating margin of -497.74% and a precarious liquidity position with a Quick Ratio of 0.20. Valuation is extreme, with a Price/Sales ratio of 31.17, suggesting the current price is driven by speculation rather than intrinsic value.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
HUT vs JPM: Head-to-Head Comparison
This page compares Hut 8 Corp. (HUT) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.